Vanguard Portfolio Management
SLS icon

Vanguard Portfolio Management’s SELLAS Life Sciences SLS Stock Holding History

Vanguard Portfolio Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9M Buy
2,161,099
+698,293
+48% +$4.82M ﹤0.01% 1844
2026
Q1 		$6.19M Buy
+1,462,806
New +$6.54M ﹤0.01% 2262

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management's SLS Position: Q2 2026 in Review

Vanguard Portfolio Management increased its SELLAS Life Sciences (SLS) stake by 48% in Q2 2026, buying an estimated $4.82M and bringing the position to 2,161,099 shares worth $31.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Vanguard Portfolio Management first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Vanguard Portfolio Management held 2,161,099 shares of SELLAS Life Sciences worth $31.9M as of Q2 2026.
  • Vanguard Portfolio Management bought 698,293 SELLAS Life Sciences shares in Q2 2026, an estimated $4.82M.
  • SELLAS Life Sciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1844 holding.
  • Vanguard Portfolio Management first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 188 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.